These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 16970919

  • 1. Inhibitors of factor VIIa affect the interface between the protease domain and tissue factor.
    Carlsson K, Persson E, Carlsson U, Svensson M.
    Biochem Biophys Res Commun; 2006 Oct 27; 349(3):1111-6. PubMed ID: 16970919
    [Abstract] [Full Text] [Related]

  • 2. Sequential coagulation factor VIIa domain binding to tissue factor.
    Osterlund M, Persson E, Carlsson U, Freskgård PO, Svensson M.
    Biochem Biophys Res Commun; 2005 Dec 02; 337(4):1276-82. PubMed ID: 16236263
    [Abstract] [Full Text] [Related]

  • 3. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
    Norledge BV, Petrovan RJ, Ruf W, Olson AJ.
    Proteins; 2003 Nov 15; 53(3):640-8. PubMed ID: 14579355
    [Abstract] [Full Text] [Related]

  • 4. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
    Kelley RF, Yang J, Eigenbrot C, Moran P, Peek M, Lipari MT, Kirchhofer D.
    Biochemistry; 2004 Feb 10; 43(5):1223-9. PubMed ID: 14756558
    [Abstract] [Full Text] [Related]

  • 5. The solution structure of human coagulation factor VIIa in its complex with tissue factor is similar to free factor VIIa: a study of a heterodimeric receptor-ligand complex by X-ray and neutron scattering and computational modeling.
    Ashton AW, Boehm MK, Johnson DJ, Kemball-Cook G, Perkins SJ.
    Biochemistry; 1998 Jun 02; 37(22):8208-17. PubMed ID: 9609717
    [Abstract] [Full Text] [Related]

  • 6. Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant.
    Zhang E, St Charles R, Tulinsky A.
    J Mol Biol; 1999 Feb 05; 285(5):2089-104. PubMed ID: 9925787
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Crystal structure of active site-inhibited human coagulation factor VIIa (des-Gla).
    Kemball-Cook G, Johnson DJ, Tuddenham EG, Harlos K.
    J Struct Biol; 1999 Oct 05; 127(3):213-23. PubMed ID: 10544046
    [Abstract] [Full Text] [Related]

  • 9. Activation loop 3 and the 170 loop interact in the active conformation of coagulation factor VIIa.
    Persson E, Olsen OH.
    FEBS J; 2009 Jun 05; 276(11):3099-109. PubMed ID: 19490111
    [Abstract] [Full Text] [Related]

  • 10. Influence of cofactor binding and active site occupancy on the conformation of the macromolecular substrate exosite of factor VIIa.
    Dickinson CD, Shobe J, Ruf W.
    J Mol Biol; 1998 Apr 10; 277(4):959-71. PubMed ID: 9545384
    [Abstract] [Full Text] [Related]

  • 11. Model of a ternary complex between activated factor VII, tissue factor and factor IX.
    Chen SW, Pellequer JL, Schved JF, Giansily-Blaizot M.
    Thromb Haemost; 2002 Jul 10; 88(1):74-82. PubMed ID: 12152682
    [Abstract] [Full Text] [Related]

  • 12. Structural changes in factor VIIa induced by Ca2+ and tissue factor studied using circular dichroism spectroscopy.
    Freskgård PO, Olsen OH, Persson E.
    Protein Sci; 1996 Aug 10; 5(8):1531-40. PubMed ID: 8844844
    [Abstract] [Full Text] [Related]

  • 13. Conformational stability of factor VIIa: biophysical studies of thermal and guanidine hydrochloride-induced denaturation.
    Freskgârd PO, Petersen LC, Gabriel DA, Li X, Persson E.
    Biochemistry; 1998 May 19; 37(20):7203-12. PubMed ID: 9585532
    [Abstract] [Full Text] [Related]

  • 14. Regulation of the catalytic function of coagulation factor VIIa by a conformational linkage of surface residue Glu 154 to the active site.
    Shobe J, Dickinson CD, Ruf W.
    Biochemistry; 1999 Mar 02; 38(9):2745-51. PubMed ID: 10052945
    [Abstract] [Full Text] [Related]

  • 15. Four loops of the catalytic domain of factor viia mediate the effect of the first EGF-like domain substitution on factor viia catalytic activity.
    Jin J, Perera L, Stafford D, Pedersen L.
    J Mol Biol; 2001 Apr 13; 307(5):1503-17. PubMed ID: 11292356
    [Abstract] [Full Text] [Related]

  • 16. The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor.
    Iakhiaev A, Ruf W, Rao LV.
    Thromb Haemost; 2001 Mar 13; 85(3):458-63. PubMed ID: 11307815
    [Abstract] [Full Text] [Related]

  • 17. Effects on the conformation of FVIIa by sTF and Ca²⁺ binding: studies of fluorescence resonance energy transfer and quenching.
    Carlsson K, Persson E, Lindgren M, Carlsson U, Svensson M.
    Biochem Biophys Res Commun; 2011 Oct 07; 413(4):545-9. PubMed ID: 21924243
    [Abstract] [Full Text] [Related]

  • 18. Spin and fluorescent probing of the binding interface between tissue factor and factor VIIa at multiple sites.
    Owenius R, Osterlund M, Svensson M, Lindgren M, Persson E, Freskgård PO, Carlsson U.
    Biophys J; 2001 Oct 07; 81(4):2357-69. PubMed ID: 11566805
    [Abstract] [Full Text] [Related]

  • 19. Probing the interface between factor Xa and tissue factor in the quaternary complex tissue factor-factor VIIa-factor Xa-tissue factor pathway inhibitor.
    Carlsson K, Freskgård PO, Persson E, Carlsson U, Svensson M.
    Eur J Biochem; 2003 Jun 07; 270(12):2576-82. PubMed ID: 12787023
    [Abstract] [Full Text] [Related]

  • 20. Solution structure of the N-terminal EGF-like domain from human factor VII.
    Muranyi A, Finn BE, Gippert GP, Forsén S, Stenflo J, Drakenberg T.
    Biochemistry; 1998 Jul 28; 37(30):10605-15. PubMed ID: 9692950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.